These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiac allograft vasculopathy after heart transplantation: current prevention and treatment strategies. Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Iliopoulos DC; Voudris V; Siasos G Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):303-311. PubMed ID: 30657571 [TBL] [Abstract][Full Text] [Related]
3. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy. Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865 [TBL] [Abstract][Full Text] [Related]
4. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P; Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361 [TBL] [Abstract][Full Text] [Related]
5. Cardiac allograft vasculopathy: Insights on pathogenesis and therapy. Lee F; Nair V; Chih S Clin Transplant; 2020 Mar; 34(3):e13794. PubMed ID: 31991002 [TBL] [Abstract][Full Text] [Related]
6. Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients. Nagumo S; Gallinoro E; Candreva A; Mizukami T; Monizzi G; Kodeboina M; Verstreken S; Dierckx R; Heggermont W; Bartunek J; Goethals M; Buytaert D; De Bruyne B; Sonck J; Collet C; Vanderheyden M J Interv Cardiol; 2020; 2020():9835151. PubMed ID: 32733172 [TBL] [Abstract][Full Text] [Related]
7. "Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy". Pighi M; Gratta A; Marin F; Bellamoli M; Lunardi M; Fezzi S; Zivelonghi C; Pesarini G; Tomai F; Ribichini F Transplant Rev (Orlando); 2020 Oct; 34(4):100569. PubMed ID: 32739137 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients. Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734 [TBL] [Abstract][Full Text] [Related]
9. Current diagnostic and treatment strategies for cardiac allograft vasculopathy. Chang DH; Kobashigawa JA Expert Rev Cardiovasc Ther; 2015 Oct; 13(10):1147-54. PubMed ID: 26401922 [TBL] [Abstract][Full Text] [Related]
16. Perfusion Cardiac Magnetic Resonance Imaging as a Rule-Out Test for Cardiac Allograft Vasculopathy. Chih S; Ross HJ; Alba AC; Fan CS; Manlhiot C; Crean AM Am J Transplant; 2016 Oct; 16(10):3007-3015. PubMed ID: 27140676 [TBL] [Abstract][Full Text] [Related]
17. Cardiac allograft vasculopathy: a review. Weis M; von Scheidt W Circulation; 1997 Sep; 96(6):2069-77. PubMed ID: 9323100 [TBL] [Abstract][Full Text] [Related]
18. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients. Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989 [TBL] [Abstract][Full Text] [Related]
19. Quantitative 3D Analysis of Coronary Wall Morphology in Heart Transplant Patients: OCT-Assessed Cardiac Allograft Vasculopathy Progression. Chen Z; Pazdernik M; Zhang H; Wahle A; Guo Z; Bedanova H; Kautzner J; Melenovsky V; Kovarnik T; Sonka M Med Image Anal; 2018 Dec; 50():95-105. PubMed ID: 30253306 [TBL] [Abstract][Full Text] [Related]